CELZ creativemedicaltechnology.com: Accounting Value per Share

Graphic logo of creativemedicaltechnology.com (CELZ)

Creative Medical Technology (CELZ) is establishing a cutting-edge regenerative therapy environment by implementing cellular developments to restore urological and neurological health. The StemSpine platform retains research participants, although strict FDA regulations are slowing commercial growth. Success relies on patent protection and the efficacy of treating dysfunctions. The growth rate of the share's book value reflects a market consensus, where the current level is 1.32.

creativemedicaltechnology.com - CELZ Net Assets per Share (period 07/04/2022 - 10/26/2026)

Creative Medical Technology Holdings, Inc. - analytical breakdowns and key metrics (CELZ)

- price and consensus price forecast:
Price Chart Creative Medical Technology Holdings Inc.|CELZ - Price Target Chart
- market capitalization data:
Market Valuation Creative Medical Technology Holdings|CELZ - Full Business Value
- book capitalization data:
Net Assets per Single Share Creative Medical Technology|CELZ - Book Valuation of Business|Market Cap to Net Assets Ratio creativemedicaltechnology.com|CELZ - Aggregate Business Assets
- debt and liquidity data:
Total Debt to Capital Creative Medical Technology|CELZ - Long-Term Liabilities to Capital|Short-Term Debt to Equity Creative Medical Technology Holdings Inc.|CELZ - Company Total Debt|Debts to Book Capitalization Creative Medical Technology Holdings
Analysis of all company metrics:creativemedicaltechnology.com - CELZ
Finished products of Creative Medical Technology Holdings Inc.

Amid Creative Medical Technology (CELZ) expansion into the regenerative medicine market, the published book value per share demonstrates capitalization efficiency driven by rising clinic demand. This indicator is calculated as the ratio of equity to the number of shares, reflecting the real value of net assets and the rate of physical resource accumulation, which allows investors to assess the business's intrinsic stability.

Competitors of Creative Medical Technology (CELZ)

MESO - Net Assets per Single Share|Lineage Corp (LCTX) - Net Assets per Single Share|Accounting Value per Share Surrozen, Inc. (SRZN)|CCEL (Cryo-Cell International, Inc.) - Share Book Value|FBLG: Net Assets per Single Share|Net Assets per Share Longeveron Inc (LGVN)|Accounting Value per Share BioRestorative Therapies